MLKL and neoplasm: Necroptosis, initiated by Receptor-Interacting Protein Kinase 1 (RIPK1)/RIPK3-MLKL signaling, leads to the release of High Mobility Group Box 1 (HMGB1) and supports cross-presentation of tumor antigens, thus linking cell death to immune surveillance.